Repligen (NASDAQ: RGEN) plan covers 5,426-share sale after option exercise

Rhea-AI Filing Summary

Repligen Corp (RGEN) received a Rule 144 notice that Olivier Loeillot intends to sell up to 5,426 shares of Repligen common stock through Fidelity Brokerage Services LLC. The shares are to be sold on or after 08/20/2026 on NASDAQ in connection with a stock option exercise.

Key Figures

Shares to be sold: 5426 shares Intended sale date: 08/20/2026 SEC file number: 000-14656

3 metrics

Shares to be sold 5426 shares Maximum Repligen common shares covered by the Rule 144 notice

Intended sale date 08/20/2026 Date listed for the planned sale and stock option exercise

SEC file number 000-14656 File number associated with Repligen Corp as issuer

Key Terms

Rule 144, Stock Option Exercise, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 08/20/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Olivier Loeillot"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing for RGEN disclose?

The filing discloses that Olivier Loeillot has notified of a planned sale of up to 5,426 RGEN common shares under Rule 144, to be executed through Fidelity Brokerage Services LLC on or after 08/20/2026.

How many Repligen (RGEN) shares are covered by this Form 144?

The notice covers up to 5,426 shares of Repligen common stock. This represents the maximum amount that may be sold under this specific Rule 144 notice and does not itself confirm that all shares will actually be sold.

Who is selling shares of Repligen (RGEN) in this Form 144?

The intended sales are for the account of Olivier Loeillot. Fidelity Brokerage Services LLC is listed as the broker, and the form is signed by Wade Moss as attorney-in-fact on Loeillot’s behalf.

On which market will the RGEN shares in this Form 144 be sold?

The shares are indicated for sale on NASDAQ. The Form 144 lists Repligen’s common stock, to be sold through Fidelity Brokerage Services LLC, with the intended sale taking place on or after 08/20/2026.

What is the relationship of the RGEN Form 144 sale to stock options?

The Form 144 states the transaction type as Stock Option Exercise. This indicates the shares to be sold are associated with an option exercise, with cash listed as the form of payment for the exercise on 08/20/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 11:54 AM Accepted by SEC EDGAR 08/20/2026 - 11:53 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001995525
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	REPLIGEN CORP
SEC File Number	000-14656
Address of Issuer	41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MASSACHUSETTS 02453
Phone	7814499560
Name of Person for Whose Account the Securities are To Be Sold	Loeillot Olivier
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5426	976680.00	56435621	08/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2026	Stock Option Exercise	Issuer			5426	08/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Olivier Loeillot
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)